-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Maintains Buy on Perspective Therapeutics, Raises Price Target to $13

Benzinga·03/18/2026 16:51:08
Listen to the news
B. Riley Securities analyst Yuan Zhi maintains Perspective Therapeutics (AMEX:CATX) with a Buy and raises the price target from $11 to $13.